In the Media

InMed’s Senior VP, Preclinical Research and Development, Dr. Eric Hsu, join the Benzinga Small Cap Conference Panel Discussion “Pharmaceutical Cannabinoids and their Impact on Treatments

Shadd Dales of The Dales Report interviews InMed CEO, Eric A. Adams, on the fast-growing synthesized cannabinoid industry and the market opportunity of rare cannabinoids.

InMed and BayMedica hosted a live webinar to talk about InMed’s acquisition of BayMedica, how it positions the company as a leader in the manufacturing